— Know what they know.
Not Investment Advice

STTK NASDAQ

Shattuck Labs, Inc.
1W: +3.2% 1M: +19.1% 3M: -9.0% YTD: +89.8% 1Y: +710.0% 3Y: +161.7% 5Y: -67.5%
$6.82
-0.22 (-3.12%)
After Hours: $7.15 (+0.33, +4.91%)
Weekly Expected Move ±12.1%
$6 $7 $7 $8 $9
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 68 · $337.2M mcap · 45M float · 3.25% daily turnover · Short 50% of daily vol
Smart Money Score
Bullish 75
Insider+$0.2M
Congress
ETF Holdings
Key Statistics
Market Cap$337.2M
52W Range0.712-8.33
Volume927,476
Avg Volume1,470,766
Beta1.06
Dividend
Analyst Ratings
9 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOTaylor H. Schreiber
Employees40
SectorHealthcare
IndustryBiotechnology
IPO Date2020-10-09
500 West 5th Street
Austin, TX 78703
US
512 900 4690
About Shattuck Labs, Inc.

Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for the treatment of ovarian, fallopian tube, and peritoneal cancers. Furthermore, Shattuck Labs is advancing another product candidate, SL-279252, which is also in Phase 1 trials for patients afflicted with advanced solid tumors and lymphoma. Established in 2016, the company maintains its corporate headquarters in Austin, Texas.

Recent Insider Trades

NameTypeSharesPriceDate
Shukla Abhinav A. M-Exempt 12,153 $3.57 2026-07-06
Shukla Abhinav A. M-Exempt 12,153 $3.57 2026-07-06
Shukla Abhinav A. M-Exempt 410 $3.57 2026-07-02
Shukla Abhinav A. S-Sale 410 $7.01 2026-07-02
Shukla Abhinav A. M-Exempt 410 $3.57 2026-07-02

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms